Phosphatidylinositol 3-kinase is required for integlrin-stimulated AKT and Raf-1/mitogen-activated protein kinase pathway activation

被引:383
作者
King, WG
Mattaliano, MD
Chan, TO
Tsichlis, PN
Brugge, JS
机构
[1] ARIAD PHARMACEUT INC,CAMBRIDGE,MA 02139
[2] FOX CHASE CANC CTR,PHILADELPHIA,PA 19111
关键词
D O I
10.1128/MCB.17.8.4406
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cell attachment to fibronectin stimulates the integrin-dependent interaction of p85-associated phosphatidylinositol (PI) 3-kinase with integrin-dependent focal adhesion kinase (FAK) as well as activation of the Ras/mitogen-activated protein (MAP) kinase pathway, However, it is not known if this PI 3-kinase-FAK interaction increases the synthesis of the 3-phosphorylated phosphoinositides (3-PPIs) or what role, if any, is played by activated PI 3-kinase in integrin signaling. We demonstrate here the integrin dependent accumulation of the PI 3-kinase products, PI 3,4-bisphosphate [PI(3,4)P-2] and PI(3,4,5)P-3, as well as activation of AKT kinase, a serine/threonine kinase that can be stimulated by binding of PI(3,4)P-2. The PI 3-kinase inhibitors wortmannin and LY294002 significantly decreased the integrin-induced accumulation of the 3-PPIs and activation of AKT kinase, without having significant effects on the levels of PI(4,S)P-2 or tyrosine phosphorylation of paxillin. These inhibitors also reduced cell adhesion/spreading onto fibronectin but had no effect on attachment to polylysine, Interestingly, integrin-mediated Erk-2, Mek-1, and Raf-1 activation, but not Ras-GTP loading, was inhibited at least 80% by wortmannin and LY294002, In support of the pharmacologic results, fibronectin activation of Erk-2 and AKT kinases was completely inhibited by overexpression of a dominant interfering p85 subunit of PI 3-kinase, We conclude that integrin-mediated adhesion to fibronectin results in the accumulation of the PI 3-kinase products PI(3,4)P-2 and PI(3,4,5)P-3 as well as the PI 3-kinase-dependent activation of the kinases Raf-1, Mek-1, Erk-2, and AKT and that PI 3-kinase may function upstream of Raf-1 but downstream of Ras in integrin activation of Erk-2 MAP and AKT kinases.
引用
收藏
页码:4406 / 4418
页数:13
相关论文
共 101 条
  • [71] Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation
    RodriguezViciana, P
    Warne, PH
    Vanhaesebroeck, B
    Waterfield, MD
    Downward, J
    [J]. EMBO JOURNAL, 1996, 15 (10) : 2442 - 2451
  • [72] ANCHORAGE DEPENDENCE, INTEGRINS, AND APOPTOSIS
    RUOSLAHTI, E
    REED, JC
    [J]. CELL, 1994, 77 (04) : 477 - 478
  • [73] Phosphatidylinositol 3-kinase activity is required for the activation process of focal adhesion kinase by platelet-derived growth factor
    Saito, Y
    Mori, S
    Yokote, K
    Kanzaki, T
    Saito, Y
    Morisaki, N
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 224 (01) : 23 - 26
  • [74] FOCAL ADHESION KINASE AND ASSOCIATED PROTEINS
    SCHALLER, MD
    PARSONS, JT
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1994, 6 (05) : 705 - 710
  • [75] PP125FAK, A STRUCTURALLY DISTINCTIVE PROTEIN-TYROSINE KINASE ASSOCIATED WITH FOCAL ADHESIONS
    SCHALLER, MD
    BORGMAN, CA
    COBB, BS
    VINES, RR
    REYNOLDS, AB
    PARSONS, JT
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (11) : 5192 - 5196
  • [76] SCHLAEPFER D, COMMUNICATION
  • [77] Integrins: Emerging paradigms of signal transduction
    Schwartz, MA
    Schaller, MD
    Ginsberg, MH
    [J]. ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 1995, 11 : 549 - 599
  • [78] Role for phosphatidylinositol 3-kinase in the regulation of beta 1 integrin activity by the CD2 antigen
    Shimizu, Y
    Mobley, JL
    Finkelstein, LD
    Chan, ASH
    [J]. JOURNAL OF CELL BIOLOGY, 1995, 131 (06) : 1867 - 1880
  • [79] ACCUMULATION OF PTDINS(3,4)P2 AND PTDINS(3,4,5)P3 IN THROMBIN-STIMULATED PLATELETS - DIFFERENT SENSITIVITIES TO CA2+ OR FUNCTIONAL INTEGRIN
    SORISKY, A
    KING, WG
    RITTENHOUSE, SE
    [J]. BIOCHEMICAL JOURNAL, 1992, 286 : 581 - 584
  • [80] SOZERI O, 1992, ONCOGENE, V7, P2259